Blog Voices from the Frontlines
PFC Offers Free Services for Laboratories To Help Address Opioid Epidemic - Americans for Safe Access
PFC Offers Free Services for Laboratories To Help Address Opioid Epidemic
Across the nation, opioid-related deaths and fatalities are decreasing in states that have medical cannabis programs, but the benefits are limited due to a lack of accurately labeled and tested cannabis products. In an effort to to help increase the number of safe and standardized medical products Americans for Safe Access will begin offering free assessments and certification services for cannabis testing laboratories through their Patient Focused Certification (PFC) program.
To receive a free laboratory assessment, click here to apply.
International Laboratory Certification Program Offers Free Services for Laboratories To Help Address Opioid Epidemic - Americans for Safe Access
Free medical cannabis laboratory assessments offered in an effort to help decrease opioid use and associated fatalities.
Washington, DC – Across the nation, opioid-related deaths and fatalities are decreasing in states that have medical cannabis programs, but the benefits are limited due to a lack of accurately labeled and tested cannabis products. Patient Focused Certification (PFC), a project of Americans for Safe Access, announced today that it will begin offering free assessments and certification services for cannabis testing laboratories to help increase the number of safe and standardized medical products, in an effort to help combat the opioid epidemic.
Dose reduction may improve pain, function, and quality of life for patients prescribed long-term opioid therapy for chronic pain. Results of a systematic evidence review are published in Annals of Internal Medicine.
Approximately 10 million U.S. adults are prescribed long-term opioid therapy for chronic pain. This dramatic increase in opioid prescribing has been accompanied by increases in opioid overdose. Expert guidelines recommend reducing or discontinuing long-term opioid therapy when risks outweigh the benefits, but evidence on the effects of dose reduction on patient outcomes had not been systematically reviewed.
In the July 2017 Issue:
- Mexico President Approves Safe Access
- Greece Announces Medical Access
- Attorney General Asks Congress to End Patient Protections
- New Revision to Cannabis Law for California
- ASA Urges Administration to Fight Opiate Crisis with Cannabis
- PFC Launches Training with Univ. of Maryland
- PFC Webinars Offer Online Help for Businesses
- ASA Activist Profile: Frank Buress, Wisconsin
- National Action Alert: Urge Congress to Renew Patient Protections
The ONLY thing protecting state medical cannabis programs from Attorney General Jeff Session’s Department of Justice (DOJ) raids and arrests is an amendment to the Commerce, Justice, Science and Related Agencies (CJS) budget that prohibits the DOJ from spending federal funds to prosecute anyone participating in a medical cannabis program as long as they are abiding by state laws.
Contact your Representative TODAY and ask them to ensure that protections for state medical cannabis programs are in the budget for fiscal year 2018.
On June 26, 2017, in Salt Lake City, patients, advocates, and their families introduced a ballot initiative application that would allow for a comprehensive medical cannabis program in Utah. The initiative grew from patient advocates and their families who are frustrated by the inability of the Utah legislators to pass comprehensive medical cannabis bills. This initiative would allow Utah voters decide if they wanted to legalize medical use of the whole cannabis plant in their state.
In the June 2017 Issue:
- CARERS Act Revived in Congress with Added Co-Sponsors
- Safe Access Tennessee Launches Grassroots Patient Groups
- PFC at Forefront of International Standards Development
- California Lobby Day Draws 200 Advocates
- Maryland Program Delays Spur Patient Protest
- ASA Activist Profile: Nichole Miller, Caregiver, Virginia
- ACTION ALERT: Urge your Senators to support CARERS!
On June 16, President Trump’s Commission on Combating Drug Addiction and the Opioid Crisis held its first meeting to begin formulating recommendations on how to combat the opioid epidemic. The meeting provided compelling stories and thoughtful suggestions on how to resolve the opioid crisis. However, the suggestions that came out of this meeting were narrow; an increase in the availability and use of Naxolone or Narcan, which is a pharmaceutical that blocks the effects of opioids, further doctor education on the prescribing of opioids, and broad adoption of CDC guidelines and basing policy on evidence based research.
Medical Cannabis Advocates Call on Trump Administration to Use all Tools Available to Fight Opiate Crisis - Americans for Safe Access
Americans for Safe Access Submits Comments at Trump’s first official meeting to address drug addiction, opioid abuse
WASHINGTON, DC — Today, June 16th, Governor Chris Christie (NJ) will chair the first meeting of the President’s commision on Drug Addiction and Combating Opioid abuse. Christie is joined on the Commission by Gov Charlie Baker (MA), Gov. Roy Cooper (NC), Rep. Patrick Kennedy and Professor Bertha Madras, Ph.D.